CRADA with DHS & TSA — joint research agreement, expanded 2026
Universal ID™ authenticates people by the vein and bone structure beneath their skin — internal imaging, where nothing can be lifted from a doorknob or scraped from a photograph. Seven issued US patents. A Cooperative Research and Development Agreement with the Department of Homeland Security and the Transportation Security Administration. A $318M exclusive licensing agreement. This page is the evidence.
7
U.S. patents issued
DHS · TSA
CRADA, expanded 2026
$318M
SDS licensing agreement
6
Biometric modalities
Intellectual property
Granted 2018 to 2022 and built continuation by continuation from a first filing — 292 days to the first patent. Assigned to Global e·dentity, with Dr. Robert Adams a named inventor on every one.
Patent no.
Issued
Subject
US 10,135,822
Nov 2018
Biometric authentication of individuals utilizing characteristics of bone and blood vessel structures — the first issued patent.
US 10,547,611
Nov 2019
Continuation of the original multimodal biometric and digital identity patent.
US 10,721,228
Aug 2020
Continuation covering advanced multimodal biometric identification and health-monitoring technology.
US 10,880,303
Dec 2020
Real-time outbreak identification via non-invasive internal imaging, for dual biometric authentication and biometric health monitoring.
US 11,277,405
Mar 2022
Dual biometric authentication and biometric health monitoring using chemosensory and internal imaging data.
US 11,368,455
Jun 2022
Multi-dimensional vascular biometric authentication, enabling non-facial identity verification for transportation and security agencies.
US 11,374,929
Jun 2022
Biometric authentication for an augmented reality or a virtual reality device.
Status
Research with DHS and TSA
Global e·dentity holds a Cooperative Research and Development Agreement with the Department of Homeland Security and the Transportation Security Administration, expanded in 2026. A CRADA is a joint research agreement. It is not a procurement award, not a contract win, and not an endorsement of Global e·dentity or Universal ID™ by either agency.
Commercial licensing
An exclusive licensing agreement with Supplier Development Systems, renewed and expanded to $318M. SDS is the exclusive licence authority liaison for Global e·dentity biometrics in Africa and other countries.
Government pipeline
Active engagements with government agencies in the Gulf and Southeast Asia.
Delivery model
Universal ID™ is delivered as a licensable multimodal biometric SDK, designed to integrate with the infrastructure you already own rather than replace it. Processing is on-device.
Who this page is for
You are bidding work that needs identity assurance stronger than fingerprint or face, and you need a technology partner whose IP position and government research record survive a due-diligence review. Universal ID™ licenses as an SDK, so it slots into a solution you already own rather than competing with it.
You are assessing biometric modalities for border, transport or credentialing programmes where spoofing external biometrics is a live threat. Seven issued US patents, an active CRADA with DHS and TSA, and six internal modalities — evaluated directly, under your own conditions.
Next step
The full briefing document — patent detail, modality specification, CRADA scope and the integration path. Sent by a member of the team, usually within one business day.
